(S (NP (NP (NNP Precision) (NN oncology)) (, ,) (NP (NP (DT the) (JJ genetic) (NN sequencing)) (PP (IN of) (NP (NNS tumors))) (SBAR (S (VP (TO to) (VP (VB identify) (NP (JJ druggable) (NNS targets))))))) (, ,)) (VP (VBZ has) (VP (VBN emerged) (PP (IN as) (NP (NP (DT the) (NN standard)) (PP (IN of) (NP (NN care))) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (JJ many) (NNS cancers))))))))) (. .))
(S (ADVP (RB Nonetheless)) (, ,) (PP (JJ due) (TO to) (NP (NP (NP (DT the) (NN pace)) (PP (IN of) (NP (NN therapy) (NN development)))) (CC and) (NP (NP (NN variability)) (PP (IN in) (NP (JJ patient) (NN information)))))) (, ,) (S (VP (VBG designing) (NP (NP (JJ effective) (NNS protocols)) (PP (IN for) (NP (JJ individual) (NN treatment) (NN assignment)))) (PP (IN in) (NP (DT a) (JJ sample-efficient) (NN way))))) (VP (VBZ remains) (NP (DT a) (JJ major) (NN challenge))) (. .))
(S (NP (NP (CD One) (VBG promising) (NN approach)) (PP (TO to) (NP (DT this) (NN problem)))) (VP (VBZ is) (S (VP (VP (TO to) (VP (VB frame) (NP (NN precision) (NN oncology) (NN treatment)) (PP (IN as) (NP (DT a) (JJ contextual) (NN bandit) (NN problem))))) (CC and) (VP (TO to) (VP (VB apply) (NP (NP (JJ sequential) (JJ decision-making) (NN algorithms)) (VP (VBN designed) (S (VP (TO to) (VP (VB minimize) (NP (NN regret)) (PP (IN in) (NP (DT this) (NN setting))))))))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (NP (DT a) (JJ clear) (NN prerequisite)) (PP (IN for) (S (VP (VBG considering) (NP (DT this) (NN methodology)) (PP (IN in) (NP (JJ high-stakes) (JJ clinical) (NNS decisions))))))) (VP (VBZ is) (NP (NP (JJ careful) (VBG benchmarking)) (SBAR (S (VP (TO to) (VP (VB understand) (NP (JJ realistic) (NNS costs) (CC and) (NNS benefits)))))))) (. .))
(S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP propose) (NP (NP (DT a) (NN benchmark) (NN dataset)) (SBAR (S (VP (TO to) (VP (VB evaluate) (NP (JJ contextual) (NN bandit) (NNS algorithms)))))) (PP (VBN based) (PP (IN on) (NP (NP (JJ real) (ADJP (IN in) (JJ vitro)) (NN drug) (NN response)) (PP (IN of) (NP (QP (RB approximately) (CD 900)) (NN cancer) (NN cell) (NNS lines)))))))) (. .))
(S (ADVP (RB Specifically)) (, ,) (NP (PRP we)) (VP (VBD curated) (NP (NP (DT a) (NN dataset)) (PP (IN of) (NP (NP (JJ complete) (NN treatment) (NNS responses)) (PP (IN for) (NP (NP (DT a) (NN subset)) (PP (IN of) (NP (CD 7) (NNS treatments))))))) (PP (IN from) (NP (JJ prior) (IN in) (JJ vitro) (NNS studies))))) (. .))
(S (NP (DT This)) (VP (VBZ allows) (S (NP (PRP us)) (VP (TO to) (VP (VB compute) (NP (NP (DT the) (NN regret)) (PP (IN of) (NP (VBN proposed) (NN decision) (NNS policies)))) (S (VP (VBG using) (NP (ADJP (RB biologically) (JJ plausible)) (NNS counterfactuals)))))))) (. .))
(S (NP (PRP We)) (VP (VP (VBD ran) (NP (NP (DT a) (NN suite)) (PP (IN of) (NP (JJ Bayesian) (NN bandit) (NN algorithms)))) (PP (IN on) (NP (PRP$ our) (NN benchmark)))) (, ,) (CC and) (VP (VBD found) (SBAR (IN that) (S (NP (DT the) (NNS methods)) (VP (VBP accumulate) (NP (NP (JJR less) (NN regret)) (PP (IN over) (NP (NP (DT a) (NN sequence)) (PP (IN of) (NP (NN treatment) (NN assignment) (NNS tasks))))) (PP (IN than) (NP (NP (DT a) (JJ rule-based) (NN baseline)) (VP (VBN derived) (PP (IN from) (NP (JJ current) (JJ clinical) (NN practice)))))))))))) (. .))
(S (NP (DT This) (NN effect)) (VP (VBD was) (ADJP (RBR more) (JJ pronounced)) (SBAR (WHADVP (WRB when)) (S (NP (JJ genomic) (NN information)) (VP (VBD was) (VP (VBN included) (PP (IN as) (NP (NN context)))))))) (. .))
(S (NP (PRP We)) (VP (VBP expect) (S (NP (DT this) (NN work)) (VP (TO to) (VP (VB be) (NP (NP (DT a) (JJ starting) (NN point)) (PP (IN for) (NP (NP (NN evaluation)) (PP (IN of) (NP (CC both) (NP (DT the) (JJ unique) (JJ structural) (NNS requirements)) (CC and) (NP (NP (JJ ethical) (NNS implications)) (PP (IN for) (NP (NP (JJ real-world) (NN testing)) (PP (IN of) (NP (NN bandit) (VBN based) (JJ clinical) (NN decision) (NN support))))))))))))))) (. .))
